Compounds > alovudine
Page last updated: 2024-08-23

alovudine and Brain Neoplasms

alovudine has been researched along with Brain Neoplasms in 44 studies

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's15 (34.09)29.6817
2010's29 (65.91)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haba, R; Kawai, N; Kudomi, N; Kushida, Y; Miyake, K; Nakamura, T; Okada, M; Shinomiya, A; Tamiya, T; Tokuda, M1
Benci, JL; Chandrasekaran, S; Davis, JJ; Dorsey, JF; Hollander, A; Kao, G; Xu, X1
Boehm-Sturm, P; Hoehn, M; Jacobs, AH; Monfared, P; Neumaier, B; Rapic, S; Viel, T1
Demirci, E; Laymon, CM; Lieberman, FS; Mountz, JM; Oborski, MJ1
Cheng, X; Navab, N; Shi, K; Ziegler, SI1
Cloughesy, TF; Dahlbom, M; Huang, SC; Phelps, ME; Schiepers, C; Wardak, M1
Bao, X; Wang, MW; Zhang, YJ; Zhang, YP1
Chen, Z; Cui, Y; Fu, Z; Kong, L; Li, M; Yang, G; Yu, J; Zhao, F1
Chen, Z; Cui, Y; Fu, Z; Li, M; Wang, Z; Yu, J; Zhao, F1
Abbas, A; Barré, L; Bernaudin, M; Collet, S; Constans, JM; Delcroix, N; Derlon, JM; Guillamo, JS; Ibazizene, M; Lechapt-Zalcman, E; Roussel, S; Valable, S1
Anish, B; Hazari, PP; Kumar, N; Mishra, AK; Rani, N; Sharma, S; Singh, B; Vyas, S; Watts, A1
Barré, L; Bernaudin, M; Bouquet, F; Corroyer-Dulmont, A; Divoux, D; Gérault, AN; Ibazizène, M; MacKenzie, ET; Pérès, EA; Petit, E; Savina, A; Toutain, J; Valable, S1
Erler, J; Kjaer, A; Lassen, U; Michaelsen, SR; Nedergaard, MK; Perryman, L; Poulsen, HS; Stockhausen, MT1
Kudomi, N; Maeda, Y; Mitamura, K; Miyake, K; Nishiyama, Y; Norikane, T; Yamamoto, Y1
Bag, AK; Desai, AS; Desideri, S; Fisher, JD; Grossman, SA; Holdhoff, M; Leal, JP; Lesser, GJ; Lieberman, FS; Lodge, MA; Mankoff, DA; Mintz, A; Mountz, JM; Nabors, LB; Schiff, D; Wahl, RL; Ye, X1
Aigbirhio, FI; Burnet, NG; Clark, JC; Cleij, MC; Dean, AF; Fryer, TD; Gillard, JH; Hutchinson, PJ; Joseph, J; Pickard, JD; Price, SJ; Salvador, R; Wang, DD1
Ichikawa, T; Kagawa, M; Kawai, N; Miyake, K; Nishiyama, Y; Shiraishi, H; Tamiya, T; Yamamoto, Y1
Backes, H; Jacobs, AH; Kracht, L; Neumaier, B; Ullrich, R; Wienhard, K1
Avril, N; Barwick, T; Bencherif, B; Mountz, JM1
D'Souza, M; Datta, A; Garg, G; Grover, RK; Jaimini, A; Kumar, N; Mishra, AK; Mondal, A; Panwar, P; Sharma, R; Singh, D; Tripathi, M; Varshney, R1
Gidding, CE; Gilles, R; Janssens, GO; Oyen, WJ; van der Vliet, TM; Vogel, WV1
Chen, W; Cloughesy, T; Czernin, J; Dahlbom, M; Huang, SC; Phelps, ME; Schiepers, C1
Burkholder, I; Combs, SE; Essig, M; Giesel, FL; Haberkorn, U; Henze, M; Kauczor, HU; Kroll, A; Meissner, M; Stieltjes, B; Tüttenberg, J; Vogt-Schaden, M; Weber, MA; Zimmer, F; Zoubaa, S1
Horky, LL; Treves, ST1
Delattre, JY; Goldman, S; Petrirena, GJ1
Chen, W; Cloughesy, T; Czernin, J; Dahlbom, M; Huang, SC; Phelps, ME; Satyamurthy, N; Schiepers, C; Wardak, M1
Jeong, SY; Lim, SM1
Hatakeyama, T; Kawai, N; Miyake, K; Okada, M; Shinomiya, A; Tamiya, T1
Backes, H; Bjerkvig, R; Brekka, N; Hoehn, M; Jacobs, AH; Jikeli, JF; Miletic, H; Monfared, P; Neumaier, B; Niclou, SP; Stieber, D; Talasila, KM; Tavitian, B; Thorsen, F; Viel, T; Waerzeggers, Y; Wang, J; Winkeler, A1
Boogaarts, HD; Grotenhuis, JA; Heerschap, A; Hoffmann, AL; Idema, AJ; Oyen, WJ; Troost, EG; van der Graaf, WT; Wesseling, P1
Aga, F; Kawai, N; Kudomi, N; Nishiyama, Y; Ono, Y; Yamamoto, Y1
Haba, R; Kawai, N; Kudomi, N; Kushida, Y; Miyake, K; Nakamura, T; Okada, M; Shinomiya, A; Tamiya, T; Tokuda, M; Yamamoto, Y1
Chen, J; Xu, T1
Hoffman, JM; Kadrmas, DJ; Rust, TC1
Choi, SJ; Kim, CJ; Kim, JH; Kim, JS; Lee, JG; Moon, DH; Oh, SJ; Ra, YS; Ryu, JS; Yeo, JS1
Bergsneider, M; Chen, W; Cloughesy, T; Czernin, J; Kamdar, N; Liau, L; Mischel, P; Phelps, ME; Satyamurthy, N; Silverman, DH1
Krohn, KA; Link, JM; Mankoff, DA; Muzi, M; Spence, AM1
Dittmar, C; Galldiks, N; Garlip, G; Heiss, WD; Herholz, K; Hilker, R; Jacobs, AH; Klein, JC; Kracht, LW; Li, H; Sobesky, J; Thomas, A; Vollmar, S; Wienhard, K1
Gault, N; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Schlienger, M; Talbot, JN; Touboul, E1
Grierson, JR; Krohn, KA; Link, JM; Mankoff, DA; Muzi, M; O'Sullivan, F; Spence, AM; Wells, JM1
Araki, N; Hashimoto, N; Higashi, T; Hiraoka, M; Hojo, M; Kawashima, H; Manabe, T; Mukai, T; Nakashima, Y; Oya, N; Saga, T; Takahashi, JA; Togashi, K1
Chen, W; Cloughesy, T; Dahlbom, M; Hoh, CK; Huang, SC; Schiepers, C1
Bradbury, MS; Burnazi, EM; Cai, S; Hambardzumyan, D; Holland, EC; Larson, SM; Longo, V; Schwartz, J; Zanzonico, PB1
Backes, H; Heiss, WD; Jacobs, AH; Kesper, K; Kracht, L; Li, H; Miletic, H; Neumaier, B; Ullrich, R; Wienhard, K1

Reviews

6 review(s) available for alovudine and Brain Neoplasms

ArticleYear
Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation.
    Nuclear medicine communications, 2009, Volume: 30, Issue:12

    Topics: Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Drug Evaluation, Preclinical; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome

2009
PET and SPECT in brain tumors and epilepsy.
    Neurosurgery clinics of North America, 2011, Volume: 22, Issue:2

    Topics: Brain; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Epilepsy; Flumazenil; Fluorodeoxyglucose F18; GABA Modulators; Humans; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2011
Advances in PET imaging of brain tumors: a referring physician's perspective.
    Current opinion in oncology, 2011, Volume: 23, Issue:6

    Topics: Brain Neoplasms; Carbon Radioisotopes; Dideoxynucleosides; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Methionine; Nitroimidazoles; Positron-Emission Tomography; Radiography; Radiopharmaceuticals

2011
Recent therapeutic advances and insights of recurrent glioblastoma multiforme.
    Frontiers in bioscience (Landmark edition), 2013, 01-01, Volume: 18, Issue:2

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Dideoxynucleosides; Glioblastoma; Humans; Immunotherapy; Interleukin-13 Receptor alpha2 Subunit; Neoplasm Recurrence, Local; Radiosurgery; Reoperation; Temozolomide

2013
True tracers: comparing FDG with glucose and FLT with thymidine.
    Nuclear medicine and biology, 2005, Volume: 32, Issue:7

    Topics: Animals; Brain; Brain Mapping; Brain Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Radionuclide Imaging; Radiopharmaceuticals; Thymidine

2005
[PET and malignant cerebral tumors].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:9 Pt 2

    Topics: Brain Neoplasms; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals

2006

Trials

4 trial(s) available for alovudine and Brain Neoplasms

ArticleYear
Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas.
    Nuclear medicine and biology, 2014, Volume: 41, Issue:8

    Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Recurrence; Survival Analysis

2014
Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma.
    Nuclear medicine and biology, 2012, Volume: 39, Issue:7

    Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Prospective Studies; Tyrosine

2012
3'-Deoxy-3'-18F-fluorothymidine PET-derived proliferative volume predicts overall survival in high-grade glioma patients.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:12

    Topics: Adult; Aged; Biological Transport; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tumor Burden

2012
[18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors.
    European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:6

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Feasibility Studies; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2005

Other Studies

34 other study(ies) available for alovudine and Brain Neoplasms

ArticleYear
3'-Deoxy-3'-[(18)F]-fluorothymidine ([(18)F]-FLT) transport in newly diagnosed glioma: correlation with nucleoside transporter expression, vascularization, and blood-brain barrier permeability.
    Brain tumor pathology, 2013, Volume: 30, Issue:4

    Topics: Adult; Aged; Antigens, CD34; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Dideoxynucleosides; Equilibrative Nucleoside Transporter 1; Female; Fluorine Radioisotopes; Glioma; Humans; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; RNA, Messenger; Young Adult

2013
18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns.
    TheScientificWorldJournal, 2013, Volume: 2013

    Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Dideoxynucleosides; Female; Glioblastoma; Humans; Metabolic Clearance Rate; Mice; Mice, Nude; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution

2013
Non-invasive imaging of glioma vessel size and densities in correlation with tumour cell proliferation by small animal PET and MRI.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:10

    Topics: Animals; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Glioblastoma; Humans; Magnetic Resonance Imaging; Methionine; Neoplasm Transplantation; Neovascularization, Pathologic; Positron-Emission Tomography; Rats; Rats, Nude

2013
Assessment of early therapy response with 18F-FLT PET in glioblastoma multiforme.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:10

    Topics: Brain Neoplasms; Dideoxynucleosides; Female; Glioblastoma; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome

2014
Direct parametric image reconstruction of rapid multi-tracer PET.
    Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention, 2013, Volume: 16, Issue:Pt 3

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Contrast Media; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Mice; Models, Biological; Neoplasms, Experimental; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity

2013
¹⁸F-FLT    and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:6

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Camptothecin; Data Interpretation, Statistical; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Glioma; Humans; Irinotecan; Kinetics; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tissue Distribution

2014
Early monitoring antiangiogenesis treatment response of Sunitinib in U87MG Tumor Xenograft by (18)F-FLT MicroPET/CT imaging.
    BioMed research international, 2014, Volume: 2014

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Dideoxynucleosides; Drug Monitoring; Early Detection of Cancer; Female; Glioblastoma; Indoles; Mice; Mice, Inbred C57BL; Mice, Nude; Multimodal Imaging; Positron-Emission Tomography; Pyrroles; Radiopharmaceuticals; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome

2014
(18)F-Fluorothymidine PET-CT for resected malignant gliomas before radiotherapy: tumor extent according to proliferative activity compared with MRI.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Postoperative Period; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden

2015
[(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas.
    NeuroImage. Clinical, 2015, Volume: 8

    Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Fluorine Radioisotopes; Glioma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Preoperative Period

2015
99mTc-MDM Brain SPECT for the Detection of Recurrent/Remnant Glioma-Comparison With ceMRI and 18F-FLT PET Imaging: Initial Results.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:10

    Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Male; Middle Aged; Organotechnetium Compounds; Pentetic Acid; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2015
Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:4

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Dideoxynucleosides; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats

2016
Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma.
    Nuclear medicine and biology, 2016, Volume: 43, Issue:3

    Topics: Animals; Bevacizumab; Brain Neoplasms; Cell Transformation, Neoplastic; Dideoxynucleosides; Female; Glioblastoma; HEK293 Cells; Humans; Mice; Microvessels; Positron-Emission Tomography; Survival Analysis; Tyrosine; Vascular Endothelial Growth Factor A

2016
Intratumoral heterogeneity of
    Annals of nuclear medicine, 2017, Volume: 31, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Brain Neoplasms; Cell Proliferation; Child; Dideoxynucleosides; Female; Glioma; Humans; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Young Adult

2017
Repeatability of
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:3

    Topics: Adult; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Grading; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; United States

2017
Imaging regional variation of cellular proliferation in gliomas using 3'-deoxy-3'-[18F]fluorothymidine positron-emission tomography: an image-guided biopsy study.
    Clinical radiology, 2009, Volume: 64, Issue:1

    Topics: Adolescent; Adult; Aged; Biopsy; Brain Mapping; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiology, Interventional; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult

2009
[Use of 11F-fluorothymidine positron emission tomography in brain tumor].
    No shinkei geka. Neurological surgery, 2009, Volume: 37, Issue:7

    Topics: Brain Neoplasms; Dideoxynucleosides; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals

2009
Noninvasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:12

    Topics: Arteries; Brain; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Glioma; Humans; Kinetics; Models, Biological; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies

2009
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Clinical nuclear medicine, 2009, Volume: 34, Issue:12

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult

2009
(18)F-fluoro-L-thymidine-PET for the evaluation of primary brain tumours in children: a report of three cases.
    Nuclear medicine communications, 2010, Volume: 31, Issue:6

    Topics: Adolescent; Brain Neoplasms; Child, Preschool; Diagnosis, Differential; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Positron-Emission Tomography

2010
Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:5

    Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Image Processing, Computer-Assisted; Kinetics; Male; Middle Aged; Models, Statistical; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Survivors; Treatment Outcome

2010
Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Investigative radiology, 2010, Volume: 45, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Biopsy; Brain Neoplasms; Choline; Contrast Media; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Microcirculation; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Spin Labels; Stereotaxic Techniques

2010
Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade glioma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Oct-15, Volume: 17, Issue:20

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Dideoxynucleosides; Discriminant Analysis; Disease-Free Survival; Female; Glioma; Humans; Irinotecan; Male; Middle Aged; Prognosis; Radionuclide Imaging

2011
Usefulness of FDG, MET and FLT-PET studies for the management of human gliomas.
    Journal of biomedicine & biotechnology, 2012, Volume: 2012

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glioma; Humans; Linear Models; Male; Methionine; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Statistics, Nonparametric

2012
Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:7

    Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Data Interpretation, Statistical; Dideoxynucleosides; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Magnetic Resonance Imaging; Methionine; Neoplasm Transplantation; Neovascularization, Pathologic; Paraffin Embedding; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Xenograft Model Antitumor Assays

2012
Correlation of 18F-FLT uptake with tumor grade and Ki-67 immunohistochemistry in patients with newly diagnosed and recurrent gliomas.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Brain Neoplasms; Child; Dideoxynucleosides; Female; Glioma; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Grading; Recurrence; Retrospective Studies; Young Adult

2012
Evaluation of 3'-deoxy-3'-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:2

    Topics: Adult; Aged; Blood-Brain Barrier; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glioma; Humans; Immunohistochemistry; Kinetics; Magnetic Resonance Imaging; Male; Middle Aged; Phosphorylation; Polymerase Chain Reaction; Thymidine Kinase

2013
Single-scan dual-tracer FLT+FDG PET tumor characterization.
    Physics in medicine and biology, 2013, Feb-07, Volume: 58, Issue:3

    Topics: Brain Neoplasms; Clinical Trials as Topic; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Injections; Positron-Emission Tomography; Time Factors

2013
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:6

    Topics: Adult; Aged; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate

2005
18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:12

    Topics: Adult; Aged; Antiviral Agents; Astrocytoma; Biological Transport; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; False Positive Reactions; Female; Glioma; Humans; Kinetics; Magnetic Resonance Imaging; Male; Medulloblastoma; Methionine; Middle Aged; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors

2005
Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:10

    Topics: Adult; Aged; Blood-Brain Barrier; Brain Neoplasms; Dideoxynucleosides; Female; Gadolinium; Glioma; Humans; Male; Middle Aged; Models, Biological; Monte Carlo Method; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals

2006
Evaluation of primary brain tumors with FLT-PET: usefulness and limitations.
    Clinical nuclear medicine, 2006, Volume: 31, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Child; Dideoxynucleosides; Feasibility Studies; Female; Humans; Male; Middle Aged; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2006
18F-fluorothymidine kinetics of malignant brain tumors.
    European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:7

    Topics: Adult; Aged; Brain Neoplasms; Computer Simulation; Dideoxynucleosides; Female; Humans; Image Interpretation, Computer-Assisted; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution

2007
Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:3

    Topics: Animals; Brain Neoplasms; Dideoxynucleosides; Disease Models, Animal; Glioma; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Mice, Knockout; Mice, Transgenic; Positron-Emission Tomography; Tissue Distribution

2008
Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Apr-01, Volume: 14, Issue:7

    Topics: Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Glioma; Humans; Immunohistochemistry; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution

2008